| Dr Matthew Howard Greenspan, MD | |
|
16001 W 9 Mile Rd, Southfield, MI 48075-4818 | |
| (248) 849-3000 | |
| Not Available |
| Full Name | Dr Matthew Howard Greenspan |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 35 Years |
| Location | 16001 W 9 Mile Rd, Southfield, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063505568 | NPI | - | NPPES |
| 4166015 | Medicaid | MI | |
| 4166015 | Other | MI | MOLINA HEALTHCARE |
| 300107168 | Other | MI | RAILROAD MEDICARE |
| 802538 | Other | MI | COMMUNITY CARE PLAN |
| 29743 | Other | MI | COMMUNITY CHOICE OF MI |
| 4166015 | Other | MI | HEALTH PLAN OF MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 4301054242 (Michigan) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 25MA09813200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Diagnostic Centers Of America, Llp | 0547174120 | 58 |
| Rmed Llc | 6608768411 | 23 |
| University Medical Center Of Southern Nevada | 7315934429 | 243 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
| Entity Name | Rmed Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508815358 PECOS PAC ID: 6608768411 Enrollment ID: O20040326000760 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
| Entity Name | Diagnostic Centers Of America, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730125261 PECOS PAC ID: 0547174120 Enrollment ID: O20080223000067 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
| Entity Name | Sheridan Radiology Services Of Pinellas Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083007454 PECOS PAC ID: 7517119407 Enrollment ID: O20121128000124 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
| Entity Name | Radiology Associates Of Southwest Louisiana |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033215710 PECOS PAC ID: 0941243562 Enrollment ID: O20130424000396 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
| Entity Name | Coastal Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710334727 PECOS PAC ID: 8123312055 Enrollment ID: O20170308001710 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
| Entity Name | Advanced Radiology Solutions |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467863068 PECOS PAC ID: 5597985507 Enrollment ID: O20170629000832 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
| Entity Name | Radiology Associates Of Wyoming Valley Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174528707 PECOS PAC ID: 2365355906 Enrollment ID: O20171226001186 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
| Entity Name | Allegiance Imaging And Radiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902346422 PECOS PAC ID: 3577838689 Enrollment ID: O20180305002228 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
| Entity Name | Riverside Radiology And Interventional Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093718496 PECOS PAC ID: 8729976964 Enrollment ID: O20180824002038 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
| Entity Name | Columbus Radiology Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669408159 PECOS PAC ID: 6507754983 Enrollment ID: O20181206003284 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
| Entity Name | Garden State Healthcare Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700014545 PECOS PAC ID: 8426190687 Enrollment ID: O20190403001579 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
| Entity Name | Western New York Mri Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043255854 PECOS PAC ID: 4082684378 Enrollment ID: O20201022003668 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
| Entity Name | Radiology Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003866583 PECOS PAC ID: 1254302573 Enrollment ID: O20210928000130 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Howard Greenspan, MD 1850 S Ocean Dr Apt 1810, Hallandale Beach, FL 33009-7680 Ph: (888) 886-5238 | Dr Matthew Howard Greenspan, MD 16001 W 9 Mile Rd, Southfield, MI 48075-4818 Ph: (248) 849-3000 |
News Archive
Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.
Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.
Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.
Preliminary clinical trial results from an ongoing Phase 2/3 trial led by Laurent M. Humeau of Inovio Pharmaceuticals suggest the two-dose INO-4800 vaccine is safe for use in adults of varying ages. The results expand on phase 1 trial results that found the vaccine was safe and tolerable in 38 participants.
› Verified 3 days ago
Anicia Mirchandani, Radiology Medicare: Medicare Enrolled Practice Location: 22250 Providence Dr, Southfield, MI 48075 Phone: 248-849-3281 | |
Carole Roseland, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 24500 Northwestern Hwy, Southfield, MI 48075 Phone: 248-353-1280 Fax: 248-353-6193 | |
Kyle Warwick Eaton, MD Radiology Medicare: Medicare Enrolled Practice Location: 16001 W 9 Mile Rd, Southfield, MI 48075 Phone: 248-849-2203 Fax: 248-849-5395 | |
Maria Crumes, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 24681 Northwestern Hwy, Southfield, MI 48075 Phone: 248-352-2000 Fax: 248-324-1477 | |
Jessica Marie Kaniowski, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 16001 W 9 Mile Rd, Southfield, MI 48075 Phone: 248-849-3000 | |
Dr. Rani Bashiti, Radiology Medicare: Accepting Medicare Assignments Practice Location: 16001 W. 9 Mild Rd,, Southfield, MI 48075 Phone: 248-849-3000 |